Christof Westenfelder, MD

Chief Executive Officer

Dr. Westenfelder is a Professor of Medicine and Physiology at the University of Utah and Chief of the Nephrology Section of the VA Medical Center.   Dr. Westenfelder has extensive experience in clinical and basic research in the field of adult stem cell biology, stem cell translational research with an emphasis in the fields of transplantation medicine and renal and critical care.   In addition, Dr. Westenfelder is an internationally recognized expert on the biology and clinical uses of erythropoietin and treatment of acute kidney and multi-organ failure.   Dr. Westenfelder has successfully founded a number of companies including Nephrogen, SymbioCellTech, LLC and Nephrocelltech, and he holds numerous patents pertinent to SCT’s technology.   He has obtained an IND from the FDA for the conduct of a successful Phase I Trial in which the safety and kidney protective activity of allogeneic, bone marrow-derived Multipotent Stromal aka Mesenchymal Stem Cells was demonstrated.


Axel Zander, MD

Vice President

Dr. Zander is emeritus Professor of Medicine and Manager of the Bone Marrow Transplantation Center at the University of Hamburg in Germany.   Dr. Zander is an internationally recognized expert in bone marrow transplantation and stem cell research, with particular expertise in novel clinical uses of adult stem cells in regenerative medicine.   Dr. Zander has founded and co-founded a number of companies including Nephrogen, SymbioCellTech, LLC and Stem Cell Rescue, and he holds numerous patents related to steam-cell therapy.


Anna Gooch, PhD

Chief Scientific Officer

Dr. Gooch graduated from the University of Utah with a PhD in Cellular, Viral and Molecular Biology. Her previous experience includes her position as Clinical Operations Manager at Allocure, Inc. She assisted in overseeing and managing a Phase 1 Clinical trial for a novel treatment of AKI, and oversaw and consulted on preclinical research. Dr. Gooch’s current duties include overseeing and conducting physical preclinical research in preparation of a Phase I/II clinical trial.


Leanne Swenson, MD

Chief Medical Officer

LeAnne Swenson, MD, Chief Medical Officer is a practicing endocrinologist with extensive scientific training in the field of diabetes and its treatment. She will contribute to the design of clinical trials and oversee their conduct.


Susan McKeever, CPA, EA, MPAcc

Chief Financial Officer

Ms. McKeever has a Bachelor of Science in Business from the University of Southern California and a Masters in Accounting from Weber State University. She is a Certified Public Accountant and an Enrolled Agent. Her experience includes positions as an Auditor and Senior Auditor for Price Waterhouse & Co., Manager of Accounting for United Technologies-Lexar, Division Controller for Southwestern Portland Cement Co., Chief Financial Officer for Prime Thyme Herbs, and Director of Accounting for SOS Staffing Services. Ms. McKeever has also held positions in private industries as Treasurer and Chief Financial Officer. She oversees financial, managerial and administrative functions and interfaces with investors.